After two virtual ECPs in a row, ESP is excited to go live again! And Basel, Switzerland is the city which will see the revival – the 34th European Congress of Pathology will take place from 3 to 7 September 2022 at the Congress Center Basel. The motto for the ECP 2022 – The Art of Next Generation Pathology – encompasses the broad range of modern pathology, including next generation technologies as well as the next generation of pathologists but also points to the intuition and…
The European Society of Pathology (ESP) would like to wish you and your Family a peaceful and joyful festive season and a healthy & happy New Year. Please accept our thanks for your continued support to the ESP, which is particularly appreciated during these challenging times. Our offices will close on Friday, 24 December 2021 and reopen on Tuesday, 4 January 2022. Sincerely,European Society of Pathology
ESDIP Newsletter – Winter 2021 edition A word from the Presidentby Catarina EloyDear Members of ESDIP, Almost two years have passed by since the COVID-19 pandemic started to dominate the news. Now, the hope on renovation of the social activities is expressed by new and old style live events on the agenda. At ESDIP, we are also living these moments with joy and hope. The cruise is navigating at good and stable speed, valuable members keep joining the active structure, contributing to renovation…
The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology announces the 2021 Pathology Progress Test (PPT). From 24th of November until 10th of December 2021 those interested are invited to take the PPT, which is primarily intended for trainees, but any pathologist curious to submit her or his knowledge base to the test is welcome to participate. The test consists of 120 questions, in a multiple-choice question (MCQ) format. The questions are partly only text, partly still…
The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology has announced the 2021 Pathology Progress Test (PPT). To allow our colleagues a few more days to prepare for the PPT, it has been decided to move the start date to Wednesday, 24 November 2021. The total period of time when the PPT will be available has been exteded by two days, being now available until Friday, 10 December. We would like to take this opportunity to remind the Colleagues who are…
Invitation for participation The European Society of Pathology (ESP) Foundation is continuing the successful organisation of External Quality Assurance (EQA) Programmes. We invite colleagues and laboratories interested in Colorectal Carcinomas EQA to register for this Scheme. Registrations are open until 1 February 2022. More information can be found in the attached flyer.
3DHISTECH is proud to announce the New Diagnostic Package Release. Please find below the latest edition of 3DHISTECH’s Release Newsletter, the official product development update for the New Diagnostic Package Release (including the Track & Sign 2.2 release). 3DHISTECH is proud to announce the New Diagnostic Package Release. Key features of this package include: • Ultra-fast Flash Z layer scanning • New settings panel for Admin user • User Interface Optimization in CaseManager• Standardized date pickers – Track&Sign New Diagnostic Product Portfolio…
The European Commision (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information among your Colleagues. Please visit the link In Vitro Diagnostic Devices Regulation (europa.eu). Sincerely,European Society of Pathology
Dear Colleagues, Molecular diagnosis has indeed become an indissociable part of the neuropathological diagnosis of brain tumors. Back in 2015 many colleagues kindly participated in our survey on methods available for the neuropathological diagnosis of CNS Tumors. We published the results of the study in Brain Pathology. https://onlinelibrary.wiley.com/doi/epdf/10.1111/bpa.12383 More recently we have also published an article highlighting the importance of assuring means for performing molecular diagnosis in all countries, richer and poorer, and have pointed out that the WHO classification should…
The European Commission (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information to your colleagues and members of the national society. Please visit the link In Vitro Diagnostic Medical Devices Regulation (europa.eu)
